Slingshot members are tracking this event:
Phase 3 presentation of Actinium Pharma's(ATNM) Iomab-B in Hematopoietic Stem Cells Transplantation expected at ASCO
Slingshot Insights Explained
Jun 04, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Iomab-b, Asco 2019, Hematopoietic Stem Cell Transplantation